Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Recent advances in the discovery of flavonoids and analogs with high‐affinity binding to P‐glycoprotein responsible for cancer cell multidrug resistance

Boumendjel, Ahcène, Di Pietro, Attilio, Dumontet, Charles, Barron, Denis · 2002 · Medicinal Research Reviews

Abstract

P‐glycoprotein (P‐gp) is a plasma membrane glycoprotein that confers multidrug resistance on cells by virtue of its ability to exclude cytotoxic drugs in an ATP‐dependent manner. The most commonly considered hypothesis is that P‐gp acts as an ATP‐driven drug‐export pump, the mechanism of which is not understood in detail. Therefore, a tremendous effort is being made to find out modulator molecules to inhibit P‐gp. We have been developing flavonoid derivatives as a new class of promising modulators using a new in vitro rational‐screening assay based on measurements of the binding‐affinity toward the C‐terminal nucleotide‐binding domain (NBD2) of P‐gp. This review is focused on our results obtained with a variety of flavonoids. Structure–activity relationships of flavonoids as potential MDR modulators are reported. © 2002 Wiley Periodicals, Inc. Med Res Rev, 22, No. 5, 512–529, 2002; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/med.10015

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/med.10015

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 162

Metadata

Authors
Boumendjel, A., Di Pietro, A., Dumontet, C., & Barron, D.
Venue
Medicinal Research Reviews
Publisher
Wiley
Published
2002-07-30
Volume
22
Issue
5
Pages
512-529
ISSN
  • 0198-6325 (ISSN-L)
  • 1098-1128
OpenAlex
W2133228174
Cited by
162
References
1
FWCI
2.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.